Atlas Trials

A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan

Clinical trial NCT01752075 · COMPLETED

Trial details

NCT number
NCT01752075
Sponsor
Celgene
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Myeloma
Start date
2011-01-01
Primary completion
2013-07-12
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.